Biodesix
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $24,041 | $26,861 | $25,555 | $28,755 |
Gross Profit | 19,381 | 22,041 | 21,350 | 23,876 |
EBITDA | -6,112 | -4,117 | -4,401 | -515 |
EBIT | -6,030 | -5,485 | -5,816 | -1,921 |
Net Income | -8,032 | -7,273 | -7,793 | -3,980 |
Net Change In Cash | 24,041 | 26,861 | 25,555 | 28,755 |
Free Cash Flow | -7,638 | -1,816 | -10,312 | 674 |
Cash | 28,409 | 29,996 | 25,572 | 18,987 |
Basic Shares | 10,660 | 10,296 | 9,656 | 8,064 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $88,499 | $71,323 | $49,087 | $38,212 |
Gross Profit | 71,780 | 55,750 | 36,077 | 24,058 |
EBITDA | -21,948 | -29,217 | -37,103 | -51,531 |
EBIT | -27,549 | -34,673 | -42,610 | -57,375 |
Net Income | -35,265 | -42,931 | -52,146 | -65,447 |
Net Change In Cash | 88,499 | 71,323 | 49,087 | 38,212 |
Free Cash Flow | -23,674 | -51,879 | -45,932 | -48,506 |
Cash | 18,987 | 26,245 | 26,284 | 43,088 |
Basic Shares | 7,551 | 6,483 | 4,105 | 2,105 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.75 |
2026-06-30 | -$0.71 |
2026-03-31 | -$0.81 |
2025-12-31 | -$0.49 |